Reading Annual report last nifht, which reconfirms all trial timelines. So by 30th Jund 2019, Immuron will have published trial data on ASH, Pediatric NASH, Cdiff. Then with 3x NASH trial data will partner/commercialise NASH. So could be trading anything between $1-$3 or Nasdaq $IMRN equivalent of $30-$90.
30th June 2019
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.8M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.9¢ | $18.98K | 190.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34537 | 9.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 63709 | 4 |
View Market Depth
| Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
10.0¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 9.9¢ | 10.0¢ | 9.8¢ | 42139 | ||
| Last updated 15.59pm 07/05/2024 ? | |||||
| IMC (ASX) Chart |